Botsen, Damien http://orcid.org/0000-0002-2117-4750
Lepoix, Elise
Mazza, Camille
Brasseur, Mathilde
Grange, Anne
Slimano, Florian
Bouché, Olivier
Article History
Received: 26 September 2018
Accepted: 9 May 2019
First Online: 17 May 2019
Compliance with ethical standards
:
: For this type of study format consent is not required.
: For this type of study format consent is not required.
: Damien Botsen reports personal fees from Pierre Fabre and non-financial support from GlaxoSmithKline, Novartis, Chugai, and Amgen outside the submitted work.Camille Mazza reports personal fees from Pierre Fabre outside the submitted work.Mathilde Brasseur reports personal fees from Bayer and non-financial support from Pierre Fabre, Novartis, Amgen, Roche, and AbbVie outside the submitted work.Olivier Bouche reports grants from Roche, personal fees from Roche, grants from Pierre Fabre, personal fees from Pierre Fabre, personal fees from Amgen, personal fees from Bayer, personal fees from Lilly, personal fees from Merck, personal fees from Novartis, outside the submitted work.Elise Lepoix, Florian Slimano, and Anne Grange: none.